alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 20,851–20,875 of 27,380 studies, newest first · page 835 of 1096.

April 2010 25

  1. 2010-04-15

    MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: Aberrant expression and function of microRNAs has been observed in AD. +3 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2010-04-15

    TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration

    ✓ Peer-reviewed Lewy body dementia Human molecular genetics

    Key finding: Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are neurodegenerative diseases with clinical and pathological overlap. +3 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2010-04-15

    Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size

    ✓ Peer-reviewed Treatments Stroke

    Key finding: Donepezil was relatively well tolerated; adverse events were consistent with current labeling. +1 more finding

    Full summary, score breakdown and related studies → Original source

  4. 2010-04-14

    Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines

    ✓ Peer-reviewed Risk factors Pharmacological reviews

    Key finding: Estrogen-based therapy therefore holds considerable promise for brain disorders that affect both men and women. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2010-04-14

    Daily medication use in nursing home residents with advanced dementia

    ✓ Peer-reviewed End-of-life care Journal of the American Geriatrics Society

    Key finding: Questionably beneficial medications are common in advanced dementia, even as death approaches. +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2010-04-13

    Current status on Alzheimer disease molecular genetics: from past, to present, to future

    ✓ Peer-reviewed Genetics Human molecular genetics

    Key finding: Linkage studies, candidate gene and whole-genome association studies have resulted in a tremendous amount of putative risk genes for Alzheimer's disease (AD). +2 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2010-04-12

    EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity

    ✓ Peer-reviewed Brain tissue and pathology Proceedings of the National Academy of Sciences of the United States of America

    Key finding: Recently, we demonstrated that the polyphenol (-)-epi-gallocatechine gallate (EGCG) inhibits alpha-synuclein and amyloid-beta fibrillogenesis. +2 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2010-04-12

    Food combination and Alzheimer disease risk: a protective diet

    ✓ Peer-reviewed Prevention and risk Archives of neurology

    Key finding: Simultaneous consideration of previous knowledge regarding potentially AD-related nutrients and multiple food groups can aid in identifying food combinations that are associated with AD risk. +2 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2010-04-12

    Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology

    ✓ Peer-reviewed Prevention and risk Neurology

    Key finding: Systematic review of the literature using the American Academy of Neurology's evidence-based methods. +1 more finding

    Full summary, score breakdown and related studies → Original source

  10. 2010-04-11

    Understanding amyloid aggregation by statistical analysis of atomic force microscopy images

    ✓ Peer-reviewed Brain scans and imaging Nature nanotechnology

    Key finding: Our results also indicate a possible general model for amyloid fibril assembly and illustrate the potential of this approach for investigating fibrillar systems.

    Full summary, score breakdown and related studies → Original source

  11. 2010-04-10

    Vascular risk factor detection and control may prevent Alzheimer's disease

    ✓ Peer-reviewed Prevention and risk Ageing research reviews

    Key finding: Prevention-by-detection of VRF and target treatment, if found effective, could significantly promote healthier mental and physical aging and lessen the socio-economic calamity anticipated from the growing prevalence of dementia.

    Full summary, score breakdown and related studies → Original source

  12. 2010-04-09

    Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI

    ✓ Peer-reviewed Long-term cohort studies NeuroImage

    Key finding: In this approach a 4D graph is used to represent the longitudinal data: edges are weighted based on spatial and intensity priors and connect spatially and temporally neighboring voxels represented by vertices in the graph. +3 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2010-04-09

    Machine-learning techniques for building a diagnostic model for very mild dementia

    ✓ Peer-reviewed Digital health tools NeuroImage

    Key finding: We found that there were significant performance differences across these seven diagnostic models.

    Full summary, score breakdown and related studies → Original source

  14. 2010-04-08

    Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study

    ✓ Peer-reviewed Getting a diagnosis Stroke

    Key finding: The Mini-Mental State Examination (MMSE) is insensitive to mild cognitive impairment and executive function. +1 more finding

    Full summary, score breakdown and related studies → Original source

  15. 2010-04-07

    MicroRNAs as biomarkers for CNS cancer and other disorders

    ✓ Peer-reviewed Genetics Brain research

    Key finding: The use of miRNAs as biomarkers has gained growing interest in the last few years. +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2010-04-06

    Korean version of mini mental status examination for dementia screening and its' short form

    ⚠ Retracted — do not rely on it Cognitive tests and assessment Psychiatry investigation

    Key finding: We developed a Korean version of Mini-Mental Status Examination (MMSE) optimized for screening dementia (MMSE-DS) and its' short form (SMMSE-DS). +3 more findings

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

    Full summary, score breakdown and related studies → Original source

  17. 2010-04-05

    Relationships between age and late progression of Parkinson's disease: a clinico-pathological study

    ✓ Peer-reviewed Brain tissue and pathology Brain : a journal of neurology

    Key finding: Cases were separated into five groups according to age at death, thus comparing patients who reached the advanced stage of the disease at different ages. +3 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2010-04-05

    Differential features of burden between spouse and adult-child caregivers of patients with Alzheimer's disease: an exploratory comparative design

    ✓ Peer-reviewed Caregiving International journal of nursing studies

    Key finding: Overall burden was greater among adult-child caregivers, especially those who lived with the patient and who had other family duties. +4 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2010-04-03

    Delirium in the emergency department: an independent predictor of death within 6 months

    ✓ Peer-reviewed Caregiving Annals of emergency medicine

    Key finding: As a result, we seek to determine whether delirium in the ED is independently associated with 6-month mortality in older patients and whether this relationship is modified by nursing home status. +3 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2010-04-01

    Drugs for Alzheimer's disease: are they effective?

    ✓ Peer-reviewed End-of-life care PubMed Central

    Key finding: Currently, five drugs have been approved by the FDA for use in AD, including four cholinesterase inhibitors and one N-methyl-d-aspartate (NMDA) receptor antagonist (see Drug Therapy). +4 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2010-04-01

    Assessment and management of pressure ulcers in the elderly: current strategies

    ✓ Peer-reviewed End-of-life care Drugs & aging

    Key finding: If the ulcer has become chronic, the ultimate goal changes from healing the wound to controlling symptoms (such as foul odour, pain, discomfort and infection) and preventing complications, thereby contributing to the patient's overall well-being; providing support for the patient's family is also important.

    Full summary, score breakdown and related studies → Original source

  22. 2010-04-01

    Trajectories of disability in the last year of life

    ✓ Peer-reviewed End-of-life care The New England journal of medicine

    Key finding: In most of the decedents, the course of disability in the last year of life did not follow a predictable pattern based on the condition leading to death.

    Full summary, score breakdown and related studies → Original source

  23. 2010-04-01

    The relationship of 60 disease diagnoses and 15 conditions to preference-based health-related quality of life in Ontario hospital-based long-term care residents

    ✓ Peer-reviewed Health systems and care delivery Medical care

    Key finding: The findings suggest that diseases affect preference-based HRQoL differently in a hospital-based LTC population compared with previous studies in the general population. +2 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2010-04-01

    Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms PloS one

    Key finding: Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease. +4 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2010-04-01

    A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline

    ✓ Peer-reviewed Hippocampus size on brain scans Brain : a journal of neurology

    Key finding: With the increased interest in the use of sequential magnetic resonance images as potential surrogate biomarkers of the disease process, it has also been shown that the rate of hippocampal atrophy is higher in persons with Alzheimer's disease compared to those with mild cognitive impairment and the healthy elderly. +4 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →